K Nollstadt

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.

Dennis M. Schmatz, M A Romancheck, L A Pittarelli et al. · Proceedings of the National Academy of Sciences · 1990 · 160 citations

Medicine, Infectious Diseases, Pharmacology +9

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies

Martha Kurtz, George K. Abruzzo, Amy Flattery et al. · Infection and Immunity · 1996 · 137 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin

Ken Bartizal, George K. Abruzzo, Charlotte Trainor et al. · Antimicrobial Agents and Chemotherapy · 1992 · 93 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis

Martha Kurtz, Cameron Douglas, J A Marrinan et al. · Antimicrobial Agents and Chemotherapy · 1994 · 71 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.

Dennis M. Schmatz, George K. Abruzzo, Maryann Powles et al. · The Journal of Antibiotics · 1992 · 64 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +10